Support Alert

Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Update on using the appropriate estimate of renal function to avoid the risk of adverse drug reactions when prescribing medicines in renal impairment.


Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society

Loading...